Market revenue in 2023 | USD 736.1 million |
Market revenue in 2030 | USD 1,887.2 million |
Growth rate | 14.4% (CAGR from 2023 to 2030) |
Largest segment | Bioreactors/fermenters |
Fastest growing segment | Cell Culture Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 31.23% in 2023. Horizon Databook has segmented the Canada upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of an effective regulatory framework for authorizing the sales of biosimilars and biologics is anticipated to positively influence the use of upstream bioprocessing in the coming decade. Health Canada is involved in introducing guidelines to help biomanufacturers comply with regulations and laws governing the approval of biopharmaceutical sales in Canada.
These ongoing initiatives are anticipated to accelerate the effective use of commercially available upstream bioprocessing products. Furthermore, companies are undertaking partnership and collaboration initiatives to expand their customer base in Canada.
For instance, in July 2023, High Purity New England (HPNE), a biopharma industry player supplying & delivering custom solutions and equipment, announced its partnership with Canada Clean Room (CCR) to distribute HPNE products in Canada.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into Canada upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account